Yulak Fatih, Joha Ziad, Öztürk Ayşegül, İnan Zeynep Deniz Şahin, Taşkıran Ahmet Şevki
Department of Physiology, School of Medicine, Sivas Cumhuriyet University, Sivas, Turkey.
Department of Pharmacology, Faculty of Pharmacy, Sivas Cumhuriyet University, 58140, Sivas, Turkey.
Mol Neurobiol. 2025 Apr;62(4):4631-4640. doi: 10.1007/s12035-024-04587-6. Epub 2024 Oct 29.
Recent studies suggest enoxaparin may protect the central nervous system (CNS) from damage. However, its specific effects on glial cells and the underlying mechanisms involving cell death and oxidative stress require further investigation. Therefore, this research investigated enoxaparin's potential to safeguard C6 glioma cells against glutamate-induced cytotoxicity, specifically focusing on its influence on oxidative stress and apoptotic mechanisms. To investigate the neuroprotective effects of enoxaparin against glutamate-induced cytotoxicity in C6 cells, four groups were established: a control group, a group exposed to 10 mM glutamate, a group treated with enoxaparin at concentrations ranging from 25 to 200 µM, and a group receiving both 10 mM glutamate and enoxaparin at concentrations ranging from 25 to 200 µM. Cell viability was measured using an XTT assay. To evaluate the effects of enoxaparin on oxidative stress, superoxide dismutase (SOD) and malondialdehyde (MDA) levels were measured using ELISA, along with total antioxidant status (TAS) and total oxidant status (TOS). Apoptosis was evaluated using flow cytometry, and caspase-3 activity, a key marker of apoptosis, was assessed using caspase-3 immunofluorescence staining. Enoxaparin at 50, 100, and 200 µM markedly increased cell viability in the enoxaparin + glutamate group. Enoxaparin treatment in the enoxaparin + glutamate group also significantly elevated levels of SOD and TAS, while concurrently decreasing MDA and TOS levels. These changes indicate a reduction in oxidative stress. Enoxaparin treatment further resulted in a significant decline in cleaved caspase-3 levels, a marker of apoptosis. Enoxaparin pre-treatment reduced cell death according to flow cytometry analysis. This study suggests enoxaparin's potential to shield C6 glioma cells from glutamate-induced cell death by mitigating both oxidative stress and apoptotic pathways. More research is needed to confirm this effect.
近期研究表明,依诺肝素可能保护中枢神经系统(CNS)免受损伤。然而,其对神经胶质细胞的具体作用以及涉及细胞死亡和氧化应激的潜在机制仍需进一步研究。因此,本研究调查了依诺肝素保护C6胶质瘤细胞免受谷氨酸诱导的细胞毒性的潜力,特别关注其对氧化应激和凋亡机制的影响。为了研究依诺肝素对C6细胞中谷氨酸诱导的细胞毒性的神经保护作用,设立了四组:对照组、暴露于10 mM谷氨酸的组、用浓度范围为25至200 μM的依诺肝素处理的组,以及同时接受10 mM谷氨酸和浓度范围为25至200 μM依诺肝素的组。使用XTT测定法测量细胞活力。为了评估依诺肝素对氧化应激的影响,使用酶联免疫吸附测定(ELISA)测量超氧化物歧化酶(SOD)和丙二醛(MDA)水平,以及总抗氧化状态(TAS)和总氧化剂状态(TOS)。使用流式细胞术评估细胞凋亡,并使用半胱天冬酶-3免疫荧光染色评估凋亡的关键标志物半胱天冬酶-3活性。在依诺肝素+谷氨酸组中,50、100和200 μM的依诺肝素显著提高了细胞活力。依诺肝素+谷氨酸组中的依诺肝素处理还显著提高了SOD和TAS水平,同时降低了MDA和TOS水平。这些变化表明氧化应激有所减轻。依诺肝素处理进一步导致凋亡标志物裂解型半胱天冬酶-3水平显著下降。根据流式细胞术分析,依诺肝素预处理减少了细胞死亡。本研究表明,依诺肝素具有通过减轻氧化应激和凋亡途径来保护C6胶质瘤细胞免受谷氨酸诱导的细胞死亡的潜力。需要更多研究来证实这种作用。